# Effects of Mifepristone on Biomarkers of Metabolic Function and Neuropsychological Performance Among Middle-Aged and Older Individuals

> **NCT01988610** · PHASE1 · COMPLETED · sponsor: **Stanford University** · enrollment: 23 (actual)

## Conditions studied

- Depression

## Interventions

- **DRUG:** 28 days treatment with Mifepristone.

## Key facts

- **NCT ID:** NCT01988610
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2017-02
- **Final completion:** 2017-02
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2018-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01988610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01988610, "Effects of Mifepristone on Biomarkers of Metabolic Function and Neuropsychological Performance Among Middle-Aged and Older Individuals". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01988610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*